OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of $865.34 million. The enterprise value is $897.71 million.
Important Dates
The next estimated earnings date is Wednesday, April 29, 2026, after market close.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OPKO Health has 759.07 million shares outstanding. The number of shares has increased by 8.23% in one year.
| Current Share Class | 759.07M |
| Shares Outstanding | 759.07M |
| Shares Change (YoY) | +8.23% |
| Shares Change (QoQ) | -1.85% |
| Owned by Insiders (%) | 42.36% |
| Owned by Institutions (%) | 25.60% |
| Float | 339.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.43 |
| Forward PS | 1.57 |
| PB Ratio | 0.68 |
| P/TBV Ratio | 11.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.97, with a Debt / Equity ratio of 0.31.
| Current Ratio | 3.97 |
| Quick Ratio | 3.21 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.02 |
Financial Efficiency
Return on equity (ROE) is -17.14% and return on invested capital (ROIC) is -16.92%.
| Return on Equity (ROE) | -17.14% |
| Return on Assets (ROA) | -6.62% |
| Return on Invested Capital (ROIC) | -16.92% |
| Return on Capital Employed (ROCE) | -12.27% |
| Weighted Average Cost of Capital (WACC) | 15.26% |
| Revenue Per Employee | $266,760 |
| Profits Per Employee | -$99,200 |
| Employee Count | 2,275 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 7.56 |
Taxes
| Income Tax | -15.71M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.33% in the last 52 weeks. The beta is 1.47, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | -31.33% |
| 50-Day Moving Average | 1.20 |
| 200-Day Moving Average | 1.33 |
| Relative Strength Index (RSI) | 45.38 |
| Average Volume (20 Days) | 2,647,948 |
Short Selling Information
The latest short interest is 32.78 million, so 4.32% of the outstanding shares have been sold short.
| Short Interest | 32.78M |
| Short Previous Month | 31.37M |
| Short % of Shares Out | 4.32% |
| Short % of Float | 9.66% |
| Short Ratio (days to cover) | 15.86 |
Income Statement
In the last 12 months, OPKO Health had revenue of $606.88 million and -$225.68 million in losses. Loss per share was -$0.30.
| Revenue | 606.88M |
| Gross Profit | 81.91M |
| Operating Income | -218.99M |
| Pretax Income | -241.39M |
| Net Income | -225.68M |
| EBITDA | -127.36M |
| EBIT | -218.99M |
| Loss Per Share | -$0.30 |
Full Income StatementBalance Sheet
The company has $364.41 million in cash and $396.78 million in debt, with a net cash position of -$32.37 million or -$0.04 per share.
| Cash & Cash Equivalents | 364.41M |
| Total Debt | 396.78M |
| Net Cash | -32.37M |
| Net Cash Per Share | -$0.04 |
| Equity (Book Value) | 1.27B |
| Book Value Per Share | 1.67 |
| Working Capital | 435.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$178.54 million and capital expenditures -$12.28 million, giving a free cash flow of -$190.82 million.
| Operating Cash Flow | -178.54M |
| Capital Expenditures | -12.28M |
| Depreciation & Amortization | 91.63M |
| Net Borrowing | -70.76M |
| Free Cash Flow | -190.82M |
| FCF Per Share | -$0.25 |
Full Cash Flow StatementMargins
Gross margin is 13.50%, with operating and profit margins of -36.08% and -37.19%.
| Gross Margin | 13.50% |
| Operating Margin | -36.08% |
| Pretax Margin | -39.78% |
| Profit Margin | -37.19% |
| EBITDA Margin | -20.99% |
| EBIT Margin | -36.08% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.23% |
| Shareholder Yield | -8.23% |
| Earnings Yield | -26.08% |
| FCF Yield | -22.05% |
Analyst Forecast
The average price target for OPKO Health is $2.03, which is 78.07% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.03 |
| Price Target Difference | 78.07% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 2.76% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.48 |
| Piotroski F-Score | 3 |
